EDP239

EDP239 · Enanta Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EDP239, covering 2016-01-29 to 2016-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Proof of Concept Study for Safety and Efficacy of EDP239 in Hepatitis C Subjects [Phase 1]